S&P TSX Capped Composite...

US Dollar vs CAD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

FWBI First Wave BioPharma Inc

2.87

0.05 (1.77%)

May 10 2024 - Closed

Delayed by 15 minutes

Form EFFECT - Notice of Effectiveness

First Wave BioPharma (NASDAQ:FWBI)
Historical Stock Chart
From Apr 2024 to May 2024

Click Here for more First Wave BioPharma Charts.

First Wave BioPharma (NASDAQ:FWBI)
Historical Stock Chart
From May 2023 to May 2024

Click Here for more First Wave BioPharma Charts.

First Wave BioPharma Inc News

First Wave BioPharma, Inc. to raise approximately $1.1 million of Gross Proceeds Priced At-the-Market
Friday 10 May 2024 (2 days ago) • GlobeNewswire Inc.

First Wave BioPharma and Celiac Journey to Host Nasdaq Event in Support of Celiac Disease Awareness Month
Thursday 9 May 2024 (3 days ago) • GlobeNewswire Inc.

Form 8-K/A - Current report: [Amend]
Wednesday 8 May 2024 (4 days ago) • Edgar (US Regulatory)

First Wave BioPharma Announces Invited Paper for Special Edition on Celiac Disease in Peer-Reviewed Scientific Journal, Nutrients
Wednesday 24 April 2024 (3 weeks ago) • GlobeNewswire Inc.

First Wave BioPharma CEO James Sapirstein to Present at the Planet MicroCap Showcase
Wednesday 17 April 2024 (4 weeks ago) • GlobeNewswire Inc.

First Wave BioPharma CEO James Sapirstein to Participate in 2024 Longwood Healthcare Leaders Conference
Monday 15 April 2024 (4 weeks ago) • GlobeNewswire Inc.

First Wave BioPharma Announces Two Abstracts on Celiac Disease Research Accepted for Presentation at the 2024 Digestive Disease Week (DDW) Conference
Monday 18 March 2024 (2 months ago) • GlobeNewswire Inc.

First Wave BioPharma Announces Completion of Business Combination with ImmunogenX, Adding Phase 3-Ready Latiglutenase to its Late-Stage GI-Focused Clinical Pipeline
Thursday 14 March 2024 (2 months ago) • GlobeNewswire Inc.

Form 8-K - Current report
Tuesday 5 March 2024 (2 months ago) • Edgar (US Regulatory)

First Wave BioPharma to Participate In ‘Fireside Chat’ at the 36th Annual Roth Conference
Tuesday 5 March 2024 (2 months ago) • GlobeNewswire Inc.

Form 424B5 - Prospectus [Rule 424(b)(5)]
Monday 4 March 2024 (2 months ago) • Edgar (US Regulatory)

First Wave BioPharma, Inc. to Raise Approximately $4.0 Million of Gross Proceeds in Registered Direct Offering
Monday 4 March 2024 (2 months ago) • GlobeNewswire Inc.

More First Wave BioPharma Inc News Articles

Fannie Mae (QB)

Intergrated Cannabis Sol... (PK)

Kraig Biocraft Laborator... (QB)

Asia Broadband (PK)

International Star (PK)

Anavex Life Sciences

Voip Pal Com (QB)

Northwest Biotherapeutics (QB)

Lightwave Logic

Impact Fusion (PK)

Bioelectronics (PK)

TPT Global Tech (CE)

Trump Media and Technology

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions